Towards adult vaccination in India: a narrative literature review.

Resham Dash, Ashish Agrawal, Vasant Nagvekar, Jayesh Lele, Alberta Di Pasquale, Shafi Kolhapure, Raunak Parikh
Author Information
  1. Resham Dash: GSK, New Delhi, India. ORCID
  2. Ashish Agrawal: GSK, Mumbai, India. ORCID
  3. Vasant Nagvekar: Lilavati Hospital & Research Centre, Mumbai, India.
  4. Jayesh Lele: Indian Medical Association, National Hospital Board of India, Mumbai, India.
  5. Alberta Di Pasquale: GSK, Wavre, Belgium. ORCID
  6. Shafi Kolhapure: GSK, Mumbai, India. ORCID
  7. Raunak Parikh: GSK, Mumbai, India. ORCID

Abstract

Despite vast improvements in childhood vaccination coverage in India, adult vaccination coverage is negligible. Our aim was, therefore, to create awareness about the importance of adult immunization. Although the true burden of vaccine-preventable diseases (VPDs) among Indian adults is unknown, adults are particularly vulnerable during outbreaks, due to a lack of immunization, waning immunity, age-related factors (e.g. chronic conditions and immunosenescence), and epidemiological shift. There are no national adult immunization guidelines in India, and although several medical societies have published adult immunization guidelines, these vary, making it unclear who should receive which vaccines (based on age, underlying conditions, etc.). Other barriers to adult immunization include vaccine hesitancy, missed opportunities, and cost. Steps to improve adult vaccination could include: adoption of national guidelines, education of healthcare providers and the public, and promotion of life-course immunization. Improving adult vaccine coverage could help reduce the burden of VPDs, particularly among older adults.

Keywords

References

  1. Indian J Med Res. 2008 Dec;128(6):699-704 [PMID: 19246792]
  2. Nat Immunol. 2013 May;14(5):428-36 [PMID: 23598398]
  3. Epidemiol Infect. 2009 Apr;137(4):570-6 [PMID: 18840317]
  4. BMC Infect Dis. 2011 Jul 29;11:205 [PMID: 21798074]
  5. Microbiol Spectr. 2016 Jun;4(3): [PMID: 27337481]
  6. Asian Pac J Cancer Prev. 2012;13(6):2643-6 [PMID: 22938435]
  7. Lancet. 2009 Oct 3;374(9696):1196-208 [PMID: 19801098]
  8. Expert Rev Vaccines. 2018 Oct;17(10):851-864 [PMID: 30350731]
  9. Eur Respir J. 2015 Nov;46(5):1407-16 [PMID: 26160871]
  10. Int J Gynaecol Obstet. 2016 Feb;132(2):146-50 [PMID: 26813261]
  11. Lancet. 2011 Jan 15;377(9761):252-69 [PMID: 21227500]
  12. Hum Vaccin Immunother. 2015;11(10):2376-88 [PMID: 26110454]
  13. Indian Pediatr. 2015 Feb;52(2):169 [PMID: 25691203]
  14. Vaccine. 2019 Jan 7;37(2):226-234 [PMID: 30527660]
  15. J Infect Dev Ctries. 2015 Apr 15;9(4):362-7 [PMID: 25881524]
  16. J Clin Diagn Res. 2017 Aug;11(8):LC20-LC23 [PMID: 28969166]
  17. Hum Vaccin Immunother. 2014;10(2):306-9 [PMID: 24128707]
  18. J Med Virol. 2016 Nov;88(11):2004-11 [PMID: 27096294]
  19. J Clin Diagn Res. 2016 Jul;10(7):DR01-3 [PMID: 27630847]
  20. Yale J Biol Med. 2017 Mar 29;90(1):135-145 [PMID: 28356901]
  21. J Family Med Prim Care. 2018 Nov-Dec;7(6):1537-1541 [PMID: 30613555]
  22. Hum Vaccin Immunother. 2015;11(9):2158-66 [PMID: 26091249]
  23. Mus Soc Issues. 2016;11(1):9-16 [PMID: 27524953]
  24. Hum Vaccin Immunother. 2015;11(9):2180-2 [PMID: 25483654]
  25. Vaccine. 2015 Aug 14;33(34):4161-4 [PMID: 25896383]
  26. Asian Pac J Cancer Prev. 2015;16(18):8473-7 [PMID: 26745104]
  27. Epidemiol Infect. 2017 Jul;145(9):1898-1909 [PMID: 28367767]
  28. Ann Am Thorac Soc. 2017 Nov;14(Supplement_5):S406-S409 [PMID: 29161078]
  29. Vaccine. 2015 Nov 27;33 Suppl 4:D114-20 [PMID: 26615170]
  30. Trop Doct. 2009 Jul;39(3):160-3 [PMID: 19535754]
  31. J Health Commun. 2017 Oct;22(10):783-791 [PMID: 28901823]
  32. Vaccine. 2008 Jul 4;26(29-30):3673-9 [PMID: 18538901]
  33. Hum Vaccin Immunother. 2018 Feb 1;14(2):430-441 [PMID: 29194019]
  34. Hum Vaccin Immunother. 2016 Aug 2;12(8):2029-2037 [PMID: 27050111]
  35. Clin Vaccine Immunol. 2017 Jul 5;24(7): [PMID: 28490424]
  36. Indian Pediatr. 2018 Dec 15;55(12):1066-1074 [PMID: 30745480]
  37. Bull World Health Organ. 2018 Jan 1;96(1):42-50 [PMID: 29403099]
  38. Lancet. 2014 Jul 5;384(9937):53-63 [PMID: 24996590]
  39. Lancet. 2011 Aug 6;378(9790):526-35 [PMID: 21664679]
  40. Emerg Infect Dis. 2018 Feb;24(2):366-369 [PMID: 29350152]
  41. NASN Sch Nurse. 2015 Jan;30(1):20-5 [PMID: 25626237]
  42. Int J Gynaecol Obstet. 2017 Jul;138 Suppl 1:47-56 [PMID: 28691334]
  43. EMBO Rep. 2008 Jul;9 Suppl 1:S13-7 [PMID: 18578017]
  44. Vaccine. 2018 Feb 1;36(6):890-898 [PMID: 29329685]
  45. Thorax. 2015 Oct;70(10):984-9 [PMID: 26219979]
  46. Int J Gynaecol Obstet. 2014 Dec;127(3):234-7 [PMID: 25085688]
  47. Prev Med. 2014 Jul;64:69-74 [PMID: 24732716]
  48. BMJ. 2009 Oct 05;339:b3926 [PMID: 19805472]
  49. J Biosci. 2001 Nov;26(4 Suppl):437-64 [PMID: 11779959]
  50. Epidemiol Infect. 2018 Mar;146(4):476-480 [PMID: 29436318]
  51. MMWR Surveill Summ. 2017 May 05;66(11):1-28 [PMID: 28472027]
  52. Indian Pediatr. 2014 Jun;51(6):441-3 [PMID: 24986275]
  53. J Glob Infect Dis. 2012 Jan;4(1):55-9 [PMID: 22529628]
  54. Lancet. 2017 Dec 2;390(10111):2437-2460 [PMID: 29150201]
  55. Lancet Infect Dis. 2015 Jun;15(6):637-8 [PMID: 26008840]
  56. Hum Vaccin Immunother. 2013 Aug;9(8):1774-8 [PMID: 23733039]
  57. Public Health Rep. 2012 Jan-Feb;127 Suppl 1:1-42 [PMID: 22210957]
  58. Asian Pac J Cancer Prev. 2014;15(15):6095-8 [PMID: 25124579]
  59. J Cancer Educ. 2017 Jun;32(2):382-391 [PMID: 26880357]
  60. Lancet. 2013 Apr 13;381(9874):1312-22 [PMID: 23541057]
  61. Indian J Med Res. 2012 Apr;135(4):529-33 [PMID: 22664502]
  62. Vaccine. 2008 Apr 16;26(17):2142-53 [PMID: 18343537]

MeSH Term

Immunization Programs
India
Vaccination
Vaccination Coverage
Vaccines

Chemicals

Vaccines

Word Cloud

Created with Highcharts 10.0.0adultimmunizationvaccinationcoverageguidelinesIndiaadultsburdenVPDsamongparticularlyconditionsimmunosenescencenationalbarriersvaccinelife-courseDespitevastimprovementschildhoodnegligibleaimthereforecreateawarenessimportanceAlthoughtruevaccine-preventablediseasesIndianunknownvulnerableoutbreaksduelackwaningimmunityage-relatedfactorsegchronicepidemiologicalshiftalthoughseveralmedicalsocietiespublishedvarymakingunclearreceivevaccinesbasedageunderlyingetcincludehesitancymissedopportunitiescostStepsimproveinclude:adoptioneducationhealthcareproviderspublicpromotionImprovinghelpreduceolderTowardsIndia:narrativeliteraturereviewAdult

Similar Articles

Cited By